FDA Peptide Reclassification 2026: What It Means for Providers The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Science Backed Uses, Benefits, Dosage, and Safety The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University